Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis

Details for Australian Patent Application No. 2009335740 (hide)

Owner AVI BioPharma, Inc.

Inventors Mourich, Dan V.; Marshall, Nikki B.; Iversen, Patrick L.

Agent Davies Collison Cave

Pub. Number AU-A-2009335740

PCT Pub. Number WO2010/080554

Priority 61/138,460 17.12.08 US

Filing date 17 December 2009

Wipo publication date 15 July 2010

International Classifications

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

A61K 31/712 (2006.01) - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose

A61K 31/7125 (2006.01) - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters

A61P 17/00 (2006.01) Drugs for dermatological disorders

Event Publications

4 August 2011 PCT application entered the National Phase

  PCT publication WO2010/080554 Priority application(s): WO2010/080554

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009335743-Sustained release of nutrients in vivo

2009335732-Systems and methods for forward osmosisfluid purification